PTC Therapeutics, Inc. (PTCT)
75.44
+1.34
(+1.81%)
USD |
NASDAQ |
Dec 11, 16:00
75.56
+0.12
(+0.16%)
After-Hours: 05:32
PTC Therapeutics Cash from Investing (Quarterly): -289.62M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 25.00M |
| Pyxis Oncology, Inc. | 11.47M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -66.30M |
| Cash from Financing (Quarterly) | 15.22M |
| Free Cash Flow | 446.25M |
| Free Cash Flow Per Share (Quarterly) | -3.702 |
| Free Cash Flow to Equity (Quarterly) | -344.46M |
| Free Cash Flow to Firm (Quarterly) | -344.95M |
| Free Cash Flow Yield | 7.20% |